Statistics

Total Visits

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study58

File Visits

Downloads
41131-1808.pdf13

Select a period of time:

Number of views in the range

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study21

Number of downloads in the range

Downloads
41131-1808.pdf2

Views

Views
June 20250
July 202515
August 20251
September 20253
October 20251
November 20251
December 20250
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • June 2025
    0
  • July 2025
    0
  • August 2025
    1
  • September 2025
    0
  • October 2025
    0
  • November 2025
    0
  • December 2025
    1
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil10
United States5
Argentina1
Ecuador1
Ethiopia1
United Kingdom1
Ireland1
Turkey1
 

Top countries by downloads

Downloads
United States2
 

Top cities views

Views
Atlanta1
Belo Horizonte1
Belém1
Brasília1
Caxambu1
Caxias do Sul1
Conceição do Coité1
Dublin1
Forfar1
Fortville1
 

Top cities by downloads

Downloads